PERPHENAZINE vs LOW‐POTENCY ANTIPSYCHOTIC DRUGS
Adverse effects ‐ movement disorders ‐ At least one movement disorder · patients with schizophrenia
Comparison 1: PERPHENAZINE showed no clear difference in adverse effects ‐ movement disorders ‐ at least one movement disorder compared with LOW‐POTENCY ANTIPSYCHOTIC DRUGS (low certainty).
1 finding from 1 review
- Perphenazine versus low‐potency first‐generation antipsychotic drugs for schizophrenia 2014 · Cochrane Headline outcomes onlyRR 15.62 [0.94, 260.49]1 study · 69 participantsLow